Rectal Culture for Detection of Fluoroquinolone-Resistant Germs and Reduced Risk of Bacteremia in Patients Undergoing Prostate Biopsy in Hospital Care Level IV
Objective: To identify fluoroquinolone resistance in rectal swabs before transrectal prostate biopsy.Materials and Methods: We reviewed clinical charts of patients who uderwent transrectal prostate biopsy between May 2011 and August 2013. We obtained a rectal swab one week before the procedure. Inta...
| Autor Principal: | Castelblanco, Diana María; Fundación Santa Fe de Bogotá |
|---|---|
| Otros Autores: | Gómez, Felipe; Universidad de los Andes, Cataño Cataño, Juan Guillermo; Pontificia Universidad Javeriana, Plata, Mauricio; Universidad de los Andes, Trujillo, Carlos Gustavo; Universidad de los Andes |
| Formato: | info:eu-repo/semantics/article |
| Idioma: | spa |
| Publicado: |
Pontificia Universidad Javeriana
2015
|
| Materias: | |
| Acceso en línea: |
http://revistas.javeriana.edu.co/index.php/vnimedica/article/view/16337 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: |
Objective: To identify fluoroquinolone resistance in rectal swabs before transrectal prostate biopsy.Materials and Methods: We reviewed clinical charts of patients who uderwent transrectal prostate biopsy between May 2011 and August 2013. We obtained a rectal swab one week before the procedure. Intake of fluoroquinolones 6 months before the biopsy was evaluated. Antibiotic prophylaxis was adjusted according the swab as follows: if it was resistant to fluoroquinolones the patient received ceftriaxone 1 g in one take, otherwise the patient received ciprofloxacine 500 mg 1 hour before the procedure and two times a day per 5 days. The follow-up was carried on during the first week before the procedure using a phone interview and during the first month with a scheduled appointment. We used the statistical software STATA 11.0.Results: A total of 761 patients underwent transrectal prostate biopsy, 554 patients had rectal swab, 254 showed resistant rectal swab, in whom 153 received Ciprofloxacin 6 months after the procedure, 7 % of all the patients presented bacteremia. None of the patients with Ceftriaxon as antibiotic prophylaxis presented bacteremia nor sepsis.Conclusions: Performing rectal swabs before biopsy is an useful stategy to identify the presence of fluoroquinolone resistant organisms, which allows to use a target antibiotic profilaxis and decrease the risk of bacteremia and infectious complications after biopsy. |
|---|